Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

IBUPROFEN

IBUPROFEN

Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview IBUPROFEN is listed in Drugs@FDA under application 076359 (ANDA).

Marketing status: Discontinued Active ingredient IBUPROFEN Form and strength TABLET, CHEWABLE;ORAL - 50MG Sponsor PERRIGO Submission history Latest submission status date: 2012-11-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview IBUPROFEN is listed in Drugs@FDA under application 076359 (ANDA). Marketing status: Discontinued Active ingredient IBUPROFEN Form and strength TABLET, CHEWABLE;ORAL - 50MG Sponsor PERRIGO Submission history Latest submission status date: 2012-11-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.